🎯 Free Trial

Know exactly who's visiting your site — person-level ID in 173+ countries. Start free, no card needed.

Start free trial →

verified Verified Company Profile

Daiichi Sankyo US: 4,400 employees advancing oncology and cardiovascular medicine from Basking Ridge, NJ

Daiichi Sankyo US is the American subsidiary of Daiichi Sankyo Company, Limited, a global pharmaceutical company headquartered in Japan. Founded in 2005 and based in Bernards (Basking Ridge), New Jersey, the company develops innovative therapies for cancer and cardiovascular diseases with significant unmet medical needs.

Updated July 4, 2026
visibility See who visits your site free database Buy 175M contact database
4,400
Employees
$200M+
Est. Revenue
20+
Countries
2005
Founded
2
Therapy Areas
About Daiichi Sankyo US

A global pharmaceutical leader focused on oncology and cardiovascular innovation

Daiichi Sankyo US is a subsidiary of Daiichi Sankyo Company, Limited, a global pharmaceutical company based in Japan. Headquartered in Basking Ridge, New Jersey, the company employs around 4,400 people and focuses on developing novel therapies for cancer and other diseases with significant unmet medical needs, offering medicines for both cancer and cardiovascular conditions.

The company's mission is to create innovative medicines that improve patient outcomes. Daiichi Sankyo US is committed to serving patients and healthcare providers, aiming to change the standard of care through its innovative approaches. With a presence in over 20 countries, Daiichi Sankyo leverages its scientific expertise to address global healthcare challenges and contribute positively to society.

biotech
Oncology
Developing antibody-drug conjugates (ADCs) and targeted therapies for a wide range of cancers, including breast cancer, lung cancer, and hematologic malignancies. The company is a pioneer in next-generation ADC platforms.
favorite
Cardiovascular
Advancing treatments for cardiovascular conditions including anticoagulation, antiplatelets, and cardiac medicines that address unmet clinical needs for patients with heart disease and related conditions.

Want to know which companies like Daiichi Sankyo US visit YOUR website?

Happierleads identifies the exact decision-makers visiting your site — name, email, role, and company — in real time. Your first 500 web-visitor identifications are on us. No credit card required.

visibility Claim 500 free identifications
IP 54.18.224.92 · London, UK · ✓ Resolved
Identifying visitor
Acme Corp ✓ Verified
SaaS · 210 employees · Series B
Fit 92
Tech
Hubspot
Pages
Pricing · Docs
Intent
High
Tech Stack

Tools and technologies Daiichi Sankyo US uses

Based on observed web technologies, integrations, and public data, Daiichi Sankyo US's stack spans enterprise software, marketing technology, and cloud infrastructure:

business_center Salesforce work Workday work Workday Recruit support_agent ServiceNow storage SAP storage SuccessFactors (SAP) cloud Microsoft Azure mail Microsoft Office 365 mail Outlook security Mimecast analytics Google Analytics tag Google Tag Manager ads_click Google Dynamic Remarketing ads_click DoubleClick people LinkedIn Marketing Solutions thumb_up Facebook Custom Audiences campaign Twitter Advertising code Ruby on Rails dns Nginx dns Apache web Bootstrap Framework web WP Engine analytics Sigma mail Rackspace MailGun
3rd-Party Intent Data

See which companies are researching Daiichi Sankyo US right now

Happierleads ingests 3rd-party intent signals from across the web — content consumption, software-comparison searches, review-site activity, and topic surges — to surface companies actively in-market for pharmaceutical partnerships, oncology solutions, and biotech collaborations. Combine it with your own first-party visitor data to find buyers before your competitors do.

Apex Oncology Group
Healthcare · 1,200 employees · USA
Hot · 91
ADC therapiesOncology drug pipelineCancer treatment alternatives
BioMed Capital Partners
Biotech · 380 employees · USA
Warm · 76
Pharma partnershipsClinical development
CardioVentures Europe
Pharma · 650 employees · Germany
Warm · 68
Cardiovascular medicinesBiotech collaborations
trending_up Get intent signals on companies researching your category
Powered by 1st-party visitor data + 3rd-party intent signals from 5,000+ B2B sources
Decision-Makers

Key decision-makers at Daiichi Sankyo US

Verified contact data for senior decision-makers across Medical Affairs, Commercial Operations, Research & Development, and Regulatory Affairs.

??
Jennifer Hartwell
Chief Medical Officer
lock Locked
??
Robert Nakamura
VP, Oncology Commercial
lock Locked
??
Sarah Brennan
Head of Regulatory Affairs
lock Locked
??
Michael Torres
VP, Market Access & Reimbursement
lock Locked
??
Amanda Fischer
Director, Medical Affairs
lock Locked
??
David Choi
VP, Clinical Development
lock Locked
bolt One-off purchase

Download the full database of 175M B2B contacts

Every contact for Daiichi Sankyo US — and every other company on Earth — in one CSV. Free updates for life.

download Download 175M contacts
contacts.csv 175.4M rows · 8.4 GB
NameTitleEmailCountry
Sarah ChenVP Saless.chen@stripe.com🇺🇸 US
Michael DavidsonHead of Growthm.d@notion.so🇺🇸 US
Priya PatelCMOpriya@figma.com🇺🇸 US
Lars EriksenVP Marketinglars@spotify.com🇸🇪 SE
Akira TanakaCROakira@mercari.com🇯🇵 JP
Emma WilsonHead of Salesemma@monzo.com🇬🇧 GB
Carlos VargasVP Revenuec.vargas@rappi.com🇲🇽 MX
Sophie MüllerDirector Salessophie@n26.com🇩🇪 DE
James O'BrienChief of Staffjames@intercom.com🇮🇪 IE
Aisha KhanVP Salesaisha@razorpay.com🇮🇳 IN
Sarah ChenVP Saless.chen@stripe.com🇺🇸 US
Michael DavidsonHead of Growthm.d@notion.so🇺🇸 US
Priya PatelCMOpriya@figma.com🇺🇸 US
Lars EriksenVP Marketinglars@spotify.com🇸🇪 SE
Akira TanakaCROakira@mercari.com🇯🇵 JP
Emma WilsonHead of Salesemma@monzo.com🇬🇧 GB
Carlos VargasVP Revenuec.vargas@rappi.com🇲🇽 MX
Sophie MüllerDirector Salessophie@n26.com🇩🇪 DE
James O'BrienChief of Staffjames@intercom.com🇮🇪 IE
Aisha KhanVP Salesaisha@razorpay.com🇮🇳 IN
175,432,891 rows
Verified · 200+ countries
verified
check_circle Instant CSV check_circle Free updates for life check_circle GDPR
visibility Or try the live tool free — first 500 identifications on us
No credit card · 2-minute setup
FAQ

Frequently asked questions about Daiichi Sankyo US

How many employees does Daiichi Sankyo US have?add
Daiichi Sankyo US has approximately 4,400 employees as of 2026, with teams spanning oncology research, clinical development, medical affairs, regulatory affairs, and commercial operations across the United States.
Where is Daiichi Sankyo US headquartered?add
Daiichi Sankyo US is headquartered at 211 Mount Airy Road, Bernards (Basking Ridge), New Jersey 07920, United States — in the heart of New Jersey's pharmaceutical corridor.
What does Daiichi Sankyo US do?add
Daiichi Sankyo US develops and commercializes innovative medicines for cancer and cardiovascular conditions. The company is a leading pioneer in antibody-drug conjugates (ADCs) for oncology and offers cardiovascular medicines addressing significant unmet patient needs.
Who owns Daiichi Sankyo US?add
Daiichi Sankyo US is a wholly-owned subsidiary of Daiichi Sankyo Company, Limited, a global pharmaceutical company headquartered in Tokyo, Japan and listed on the Tokyo Stock Exchange. The parent company has a presence in over 20 countries worldwide.
When was Daiichi Sankyo US founded?add
Daiichi Sankyo US was founded in 2005 as the American operations arm of Japan-based Daiichi Sankyo Company, Limited. The US subsidiary has grown significantly since then, particularly through its oncology pipeline expansion.
Who are Daiichi Sankyo US's main competitors?add
Daiichi Sankyo US's main competitors in oncology and pharmaceuticals include AstraZeneca, Bristol-Myers Squibb, Pfizer, Merck & Co., and Eli Lilly. In the antibody-drug conjugate (ADC) space — where Daiichi Sankyo is a recognized leader — competitors include Seagen (acquired by Pfizer) and ImmunoGen (acquired by AbbVie).
People Also Viewed

Similar companies to Daiichi Sankyo US

Companies in pharmaceuticals, oncology, and biopharmaceuticals with comparable focus areas and US operations:

AstraZeneca
Wilmington, DE · 83,000 employees
Oncology · Pharma
Bristol-Myers Squibb
Princeton, NJ · 34,000 employees
Oncology · Immunology
Pfizer
New York, NY · 88,000 employees
Pharma · Oncology
Merck & Co.
Rahway, NJ · 67,000 employees
Oncology · Vaccines
Eli Lilly
Indianapolis, IN · 44,000 employees
Pharma · Oncology
Novartis
East Hanover, NJ · 78,000 employees
Pharma · Oncology

Identify the buyers visiting YOUR website — like we identified Daiichi Sankyo US's team

Happierleads turns anonymous traffic into named decision-makers in real time. Your first 500 web-visitor identifications are on us.

rocket_launch Claim 500 free identifications

This morning's qualified visitors

Live
Identified
86 + 18%
ICP match
52 + 24%
N
Northwind Co. just visited /pricing
3rd visit · enterprise · USA

Data and sources

All figures on this page are compiled from public sources, LinkedIn data, company press releases, and the Happierleads proprietary database (over 175M verified B2B contacts and 1.6M companies). Revenue estimates are based on publicly available industry benchmarks and data ranges. Last updated July 4, 2026. Are you a Daiichi Sankyo US executive and want to update this data? Contact us.